ABSTRACT A study of 2800 workers employed in three factories of the two major manufacturers of enzymatic products in the United Kingdom covering 11 years of operation from 1969 to 1980 showed that 2344 workers had sufficient lung function data to meet the operational criteria and these were analysed in three separate groups by factory locations. Spirometry and prick tests for specific skin reactions to standardised enzyme were performed at six monthly intervals for the first six years of the study and then annually. Factory enzyme dust and total dust measurements were made to determine the degree of dust exposure of the subjects. The lung function of the factory groups was analysed for the effects of working in the detergent industry, the degree of exposure to enzymes, skin prick test positivity to enzymes, atopicity, and smoking. The 4 5 % of workers who had experienced respiratory effects from enzymes were analysed separately. Exposure to the enzyme allergen has had no significant long term effect on the lung function of the detergent workers. A higher proportion of atopics than non-atopics became skin test positive to the allergen and more smokers than non-smokers were sensitised. The overall lung function of detergent workers showed 39 ml/year loss in FEV, on the 11 year longitudinal study and 51 ml/year loss on the lateral (cross sectional) analysis with better lung function in the south east than the north west of England. In the development of the methodology for the study several potential problems were discovered that could remain unrecognised in a cross sectional analysis performed in isolation.
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Detergent products containing enzymes were first manufactured in the United Kingdom in 1968 and allergic reactions to them have been reported.' 8 The Soap and Detergent Industry Association (SDIA) medical recommendations9 have been followed since 1969 . SDIA and other studies have shown a pronounced reduction in enzyme related respiratory incidents corresponding to the environment improvements in the factories in the United Kingdom.79 There was no overall relationship between changes in lung function and the duration of contact of workers with atmospheric enzyme dust.
An international symposium held in May 1976 concluded that enzymes used in detergents can produce an IgE mediated asthma that is dose related but respiratory disease other than asthma is unlikely to arise from the use of these enzymes. ' Information obtained from the MRC based questionnaire, medical history, and physical examinations is not described in this paper.
ANALYSIS OF RESULTS
The workers have been analysed in three separate groups by factory locations A, B, and C. Factory A is in southern England and factories B and C in the 
EFFECT OF ATOPY
After the SDIA recommendations in 1969,9 no new atopic employees (as defined) were placed in enzyme detergent manufacturing areas, but this policy did not come into operation until two years after enzyme production had started. Atopics with symptoms were removed, and so the number of atopics was fewer than would be expected. There was no difference in lung function between the groups.
In a population that includes subjects excluded from the lung function analysis (because of insufficient lung function data) the effects of atopy and level of exposure on conversion to -skin test positivity have been analysed; the results are shown in table 4. A significantly higher percentage of atopics (particularly in factory A where initial dust exposure levels were high) became sensitised compared with non-atopics, but the average time taken to become postive was similar, except at Factory A, where non-atopics took significantly longer to become PT+. Between factories A, B, and C there is a substantial difference in the overall time taken to reach positivity, with Factory C workers being sensitised in half the time taken at factories A and B.
In factory C significantly more subjects in the maximum exposure areas converted to PT+ve, and did so in a significantly shorter time. These trends are also present in factory B atopics. There are, however, anomalies between the maximum and medium groupings in factories A and B. This may result from the low enzyme dust levels from 1972 onwards which gave similar exposures to these groups.
EFFECT OF SMOKING
Smokers were classified by the MRC questionnaire, but in practice it was found that the most important factor was whether an employee smoked or not during the period covered by the lung function measurements. Smokers have a greater FEV, loss than non-smokers and the differences are statistically significant for factory C (table 5) .
At the three factories the smoking habits of 2714 subjects were known. The relative conversion rates to skin test positivity to enzymes were determined for the smokers and non-smokers and a higher percentage of smokers than non-smokers became skin test positive to the enzyme.
EFFECT ON WORKERS WHO HAVE EXPERIENCED RESPIRATORY HYPERSENSITIVITY (E CASES)
A total of 126 E cases was recognised and sufficient lung function data were collected on 106; the results of the statistical analyses are shown in Lowe2' and Kauffmann22 from chronic obstructive pulmonary disease tend to (neither was cited by Glindmeyer). Lowe studied be higher in the north and west compared with the two groups of south Wales steelworkers, only men south and east even when allowance is made for the with normal chests being admitted, and gives figures The large reduction in enzyme dust levels coincided with a drop in the rate of conversion of those atopics still exposed post 1969 to a percentage equivalent to the post 1969 non-atopics. The time taken to become skin test positive to enzymes did not differ between atopics and non-atopics. With the lowering of enzyme dust levels through the 1970s, by enzyme encapsulation, and better industrial hygiene measures, the percentage rate of conversion to skin test positive of newly employed non-atopics was reduced significantly but, for those who became sensitised, the time taken was still about the same. These results are supported by conversion versus exposure levels.
The adverse effect on sensitisation and lung function of smoking confirms the findings of other investigations.24 25 An FEV, loss of 50 to 100 ml/year has been shown for smokers26 and a higher percentage of smokers became skin test positive to the enzyme than non-smokers. 25 The lung function of the 20 E cases who are also smokers has not returned to its expected level. It is not possible to determine if the loss is caused by enzymes or smoking. Smoking status could account for their relative rate of loss and this could be due to respiratory obstruction which does not (initially) produce symptoms. 27 Only three E cases (one at factory A and two at factory C) were identified whose lung function had not returned to its previous level for no other reason than enzymes.
The total percentage of E cases was 4-5% 
